Why Peak Performers Are Microdosing (And It's Not What You Think)

While you're dialing in your morning routine and optimizing your supplement stack, Google co-founder Sergey Brin and other high-performers have discovered a cognitive enhancement protocol that's fundamentally different from anything in your “biohacking” toolkit.

Wall Street Journal recently reported that Sergey Brin "occasionally enjoys magic mushrooms in small amounts," implying microdosing-like practices for enhanced performance in high-stakes environments¹.

This isn't an isolated case — it's part of a documented trend that's transforming how elite performers approach cognitive optimization.

The reality is that psilocybin microdosing has moved far beyond the stereotypical Silicon Valley programmer experimenting with consciousness.

Recent coverage in Fortune documents CEO retreats where executives use psilocybin to "surface limiting behaviors and become more compelling leaders"². The New York Times has similarly reported on CEO retreats involving psilocybin for leadership improvement, with anonymous executives claiming enhanced authenticity and decision-making³.

What changed everything for the performance optimization world was discovering that you don't need a full psychedelic experience to access the neuroplasticity and cognitive flexibility benefits. Research suggests that sub-threshold doses of psilocybin can enhance pattern recognition, creative problem-solving, and emotional regulation without any perceptual changes⁴.

This isn't about getting high or having spiritual experiences. This is about gaining a measurable competitive edge in high-stakes environments where cognitive performance directly translates to bottom-line results.